Three Points of Diversion Prevention Failure - On Demand
Recorded On: 06/02/2022
-
Register
- Prices available after logging in
Drug Diversion can occur anywhere there is access to controlled substances and high-value medications. The home infusion setting brings its own unique challenges and areas of risk. It also brings opportunity for real impact in the patient’s home surrounding substance abuse. Join us as we discuss the main points of failure and learn how we can close those gaps to make things safer for our patients and healthcare professionals.
Learning Objectives:
- Define drug diversion and its prevalence among healthcare professionals.
- Recognize the need to evaluate chain of custody procedures for controlled substances.
- Recognize unusual events that may warrant diversion consideration.
Theresa Vidals
Pharmacist
Rxpert Solutions
Theresa “Terri” has been a pharmacist for over 30 years with 15 years of experience inmedication safety and drug diversion monitoring. Her background includes work in variousclinical roles, as well as leadership roles such as Pharmacy Operations Manager, MedicationSafety Officer and Pharmacy Director. She has overseen and started diversion monitoringprograms at healthcare facilities. Terri is a subject matter expert in drug diversion preventionand monitoring. In addition to her years of experience in hospital pharmacy and involvement indrug diversion prevention and monitoring, she possesses the ability to see the big picture. Sheknows what to look for and how to look for it. While she is compassionate toward healthcareprofessionals that have a substance abuse problem, she also understands the safety risks andis not afraid to ask the hard questions during investigation interviews. She is also the host ofDrug Diversion Insights, a podcast for those in the healthcare industry looking for ways toreduce substance abuse and drug diversion. She founded Rxpert Solutions so that all facilitieswould have access to her expertise as an alternative to, or to act as a bridge while waiting for,personnel on site to develop the expertise.
No Disclosures to Report